Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Physiomics ( (GB:PYC) ) has shared an update.
Physiomics plc, a leading AIM‑quoted modelling and data science company serving biotech and pharma clients in oncology and other therapeutic areas, uses bespoke computational models and biostatistics to inform drug development. Its Virtual Tumour platform and related services have supported more than 140 commercial projects for major partners such as Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics and Cancer Research UK.
The company has launched a dedicated website to inform shareholders ahead of its requisitioned general meeting scheduled for 29 April 2026. The site centralises the circular on the requisition, the board’s position and recommendations, and practical voting details, underlining Physiomics’ emphasis on transparency and shareholder engagement as it navigates governance matters that could influence its strategic direction.
Spark’s Take on PYC Stock
According to Spark, TipRanks’ AI Analyst, PYC is a Neutral.
The score is held back primarily by weak financial performance (ongoing losses and persistent cash burn), partially offset by a low-leverage balance sheet and some improvement in price trend. Valuation is constrained by negative earnings and lack of dividend support.
To see Spark’s full report on PYC stock, click here.
More about Physiomics
Physiomics plc is a UK‑listed mathematical modelling, data science and biostatistics specialist focused on supporting the development of new therapeutics and personalised medicine solutions. The company applies modelling and simulation, biostatistics, bioinformatics and its proprietary Virtual Tumour technology to help biotech and pharma clients streamline drug development and de‑risk decision‑making across discovery, pre‑clinical and clinical stages.
Average Trading Volume: 7,913,348
Technical Sentiment Signal: Sell
Current Market Cap: £2.15M
For detailed information about PYC stock, go to TipRanks’ Stock Analysis page.